Spots Global Cancer Trial Database for oraxol
Every month we try and update this database with for oraxol cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Ph3 Study To Determine Safety,Tolerability&Tumor Response Of Oraxol Compared To Taxol In Metastatic Breast Cancer | NCT02594371 | Metastatic Brea... | Oraxol IV paclitaxel | 18 Years - | Athenex, Inc. | |
| A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oraxol in Subjects With Advanced Malignancies | NCT01967043 | Solid Tumor | Oraxol | 18 Years - | Athenex, Inc. | |
| Ph1b Study of Oraxol in Comb. w. Ramucirumab in Patients w. Gastric, Gastro-esophageal, or Esophageal Cancers | NCT02970539 | Gastric Cancer Esophageal Canc... Gastro-esophage... | Oraxol Ramucirumab | 18 Years - | Athenex, Inc. | |
| Study of Oraxol and Pembrolizumab in Subjects With Advanced Solid Tumors | NCT03588039 | Solid Tumor | Oraxol Pembrolizumab | 18 Years - 99 Years | Athenex, Inc. | |
| An Extension Study to Provide Oraxol to Patients Who Completed KX-ORAX-007 | NCT04168957 | Breastcancer | Oraxol | 18 Years - | Athenex, Inc. | |
| Study of Oraxol and Pembrolizumab in Subjects With Advanced Solid Tumors | NCT03588039 | Solid Tumor | Oraxol Pembrolizumab | 18 Years - 99 Years | Athenex, Inc. | |
| A PK Study of Oraxol in Breast Cancer Patients | NCT04993040 | Breastcancer | Oraxol | 18 Years - | Athenex, Inc. | |
| Study of Oraxol and Pembrolizumab in Subjects With Advanced Solid Tumors | NCT03588039 | Solid Tumor | Oraxol Pembrolizumab | 18 Years - 99 Years | Athenex, Inc. | |
| A PK Study of Oraxol in Breast Cancer Patients | NCT04993040 | Breastcancer | Oraxol | 18 Years - | Athenex, Inc. | |
| Ph1b Study of Oraxol in Comb. w. Ramucirumab in Patients w. Gastric, Gastro-esophageal, or Esophageal Cancers | NCT02970539 | Gastric Cancer Esophageal Canc... Gastro-esophage... | Oraxol Ramucirumab | 18 Years - | Athenex, Inc. | |
| The Effect of Food on the Pharmacokinetics of Paclitaxel Administered Orally as Oraxol | NCT03892018 | Solid Tumor, Ad... | Oraxol | 18 Years - | Athenex, Inc. | |
| A Study of Oraxol in Subjects With Cutaneous Angiosarcoma | NCT03544567 | Angiosarcoma of... | Oraxol | 18 Years - 100 Years | Athenex, Inc. | |
| A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oraxol in Subjects With Advanced Malignancies | NCT01967043 | Solid Tumor | Oraxol | 18 Years - | Athenex, Inc. | |
| A Study of Oraxol in Subjects With Cutaneous Angiosarcoma | NCT03544567 | Angiosarcoma of... | Oraxol | 18 Years - 100 Years | Athenex, Inc. | |
| A PK Study of Oraxol in Breast Cancer Patients | NCT04993040 | Breastcancer | Oraxol | 18 Years - | Athenex, Inc. | |
| A Study of Oraxol in Subjects With Cutaneous Angiosarcoma | NCT03544567 | Angiosarcoma of... | Oraxol | 18 Years - 100 Years | Athenex, Inc. | |
| An Extension Study to Provide Oraxol to Patients Who Completed KX-ORAX-007 | NCT04168957 | Breastcancer | Oraxol | 18 Years - | Athenex, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
